← All companies

BLTE

Belite Bio, Inc

BLTE Nasdaq Pharmaceutical Preparations EDGAR ↗

$154.79

-5.13 -3.21%

Key statistics

from XBRL data in SEC filings

Market cap

$6.09B

Revenue (TTM)

—

Net income (TTM)

-$77.6M

EPS (TTM)

$-2.31

P/E ratio

—

Dividend yield

—

Free cash flow

-$37.1M

Cash

$353M

Total assets

$781M

Gross margin

—

52-week range

$60.00 – $200.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 15, 2026 6-K FORM 6-K May 20, 2026 6-K Apr 21, 2026 6-K FORM 6-K Mar 31, 2026 20-F Mar 31, 2026 6-K FORM 6-K Mar 2, 2026 6-K FORM 6-K Jan 27, 2026 6-K FORM 6-K Dec 2, 2025 6-K FORM 6-K Dec 1, 2025 6-K FORM 6-K Dec 1, 2025 6-K FORM 6-K Dec 1, 2025 6-K FORM 6-K Nov 10, 2025 6-K FORM 6-K Sep 8, 2025 6-K FORM 6-K Aug 11, 2025 6-K FORM 6-K Aug 7, 2025 6-K FORM 6-K Jul 2, 2025 6-K FORM 6-K May 21, 2025 6-K FORM 6-K May 14, 2025 6-K FORM 6-K Apr 15, 2025 6-K FORM 6-K Mar 28, 2025 6-K FORM 6-K Mar 18, 2025 6-K FORM 6-K Mar 17, 2025 6-K FORM 6-K Mar 17, 2025 20-F Mar 17, 2025 6-K FORM 6-K Feb 27, 2025 6-K FORM 6-K Feb 6, 2025 6-K FORM 6-K Nov 12, 2024 6-K FORM 6-K Nov 4, 2024 6-K FORM 6-K Sep 3, 2024 6-K FORM 6-K Aug 9, 2024 6-K FORM 6-K May 14, 2024 6-K FORM 6-K Apr 26, 2024 6-K FORM 6-K Mar 22, 2024 6-K FORM 6-K Mar 12, 2024 20-F FORM 20-F Mar 12, 2024 6-K FORM 6-K Mar 12, 2024 6-K FORM 6-K Nov 14, 2023 6-K FORM 6-K Nov 6, 2023 6-K FORM 6-K Aug 9, 2023 6-K FORM 6-K Jul 24, 2023